Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators (Q42557234)

2 November 2017

title

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators (English)

1 reference

left ventricular dysfunction

2 November 2017

main subject

ventricular dysfunction

1 reference

based on heuristic

inferred from title

1 reference

1 reference

Jeffrey L Probstfield

object named as

Probstfield J

1 reference

2 November 2017

Kostis JB

1 reference

2 November 2017

Shelton B

1 reference

2 November 2017

Gosselin G

1 reference

2 November 2017

Goulet C

1 reference

2 November 2017

Hood WB Jr

1 reference

2 November 2017

Kohn RM

1 reference

2 November 2017

Kubo SH

1 reference

2 November 2017

Schron E

1 reference

2 November 2017

Weiss MB

1 reference

2 November 2017

Willis PW 3rd

1 reference

2 November 2017

Young JB

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

2 November 2017

published in

American Heart Journal

1 reference

2 November 2017

volume

131

1 reference

2 November 2017

1 reference

2 November 2017

page(s)

350-355

1 reference

Angiotensin converting enzyme inhibition in patients with congestive heart failure

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Angiotensin converting enzyme inhibitors. II. Clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990365-8

10.1016/S0002-8703(96)90365-8

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference